---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-022824"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2026-04-01T23:59:59+00:00"
generated_at: "2026-05-15T08:00:44.912787+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Senti Biosciences to form holding company via tax-free merger; stock to trade as SNTI

## Summary
- Holding company reorganization effective April 16, 2026 via merger into Senti Biosciences Holdings.
- Each share of common stock automatically converts into one share of holding company common stock with same rights.
- No stockholder vote or action required; no gain/loss recognized for U.S. federal income tax purposes.
- New holding company will have same directors, officers, assets, and operations as current company.
- Stock continues trading on Nasdaq under SNTI with a new CUSIP number.

## SEC filing metadata
- accession: 0001628280-26-022824
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2026-04-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000162828026022824/0001628280-26-022824-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000162828026022824/snti-20260401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-022824
- JSON: https://secwatch.observer/filing/0001628280-26-022824.json
- Plain text: https://secwatch.observer/filing/0001628280-26-022824.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.